Furthermore, subgroup analyses according to tumor resectability and the treatment and detection methods of K-ras still revealed that K-ras gene mutations were strongly correlated with poorer prognoses in patients with pancreatic cancer. This evidence concerns the gene KRAS and pancreatic neoplasm.